ABBV vs PFE

AbbVie Inc. vs Pfizer, Inc. · Healthcare · scored 2026-08-04

ABBVAbbVie Inc.59 Gem
VSEdge pick: ABBV — AbbVie Inc.higher Gem Score
PFEPfizer, Inc.54 Gem

Head-to-head

The numbers that matter, side by side. A star marks the stronger stock on each merit measure.

MeasureABBVPFE
Gem Score59/100 ★54/100
Strategies agreeing4 ★4
Price$245.10$25.03
Market cap$433B$143B
Market regimeBullishBearish
Best-fit thesisCAN SLIMLow-Vol Defensive
Win probability48% · 46%
Estimated edge+28.8% · +24.8%

Modeled from the GemStox stochastic + volatility models (order: ABBV · PFE). Not financial advice.

Strategy-thesis head-to-head

GemStox scores each stock across 14 independent investment theses. Here is where they differ.

Strategy thesisABBVPFEΔ
GARP
95
★
51
+45
Mean Reversion
12
46
★
-34
Quality Compounder
59
71
★
-12
CAN SLIM
80
★
17
+63
Low-Vol Defensive
40
88
★
-48
Catalyst / Event
41
★
31
+10
Dividend Growth
22
★
22
+1
S-Curve Growth
32
32
+0
Piotroski F-Score
44
78
★
-33
Operating Leverage
100
★
5
+95
Net Payout Yield
40
80
★
-40

ABBV leads 5, PFE leads 5, 1 tied — of 11 comparable theses

Dimension by dimension

Average sub-signal score across valuation, quality, risk, growth, and momentum.

DimensionABBVPFE
Valuation
80
★
50
Quality
58
★
53
Risk
36
78
★
Growth
56
★
28
Momentum & Technicals
31
★
27

How this comparison is computed

Every figure is computed from the same cached market + fundamentals data GemStox uses to score individual stocks — no two theses double-count. Try the free Stock Score calculator, read the full scoring methodology, or open either single-stock analysis above for the full 14-signal breakdown.

Free: compare any stocks in the live app →

Open the GemStox Compare tool and put any two (or up to ten) tickers head-to-head — live win probability, optimal position size, and pre-calculated stop/target levels. It's free to try: 3 comparisons a day, no account, then upgrade from $3 for unlimited.

Compare free in the app →

Educational comparison generated from cached market + fundamentals data as of 2026-08-04. Not investment advice. Past performance does not guarantee future results.